Nasopharyngeal Carcinoma Clinical Trials

520 clinical trials for Nasopharyngeal Carcinoma across international registries, including 101 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors — RECRUITING · PHASE2
• Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC) — RECRUITING · PHASE2
• Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma — RECRUITING · NA
• [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers — RECRUITING · PHASE1
• RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC — RECRUITING
• Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors — RECRUITING · PHASE1
• CD70-targeted immunoPET Imaging of Malignant Cancers — RECRUITING · PHASE2
• IC Plus Low-dose Radiation Plus Cadonilimab in LANPC — RECRUITING · PHASE3
• Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial — RECRUITING · PHASE3
• Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC — RECRUITING
• SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition — RECRUITING · PHASE3
• Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma — RECRUITING · PHASE1
• Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC — RECRUITING · PHASE3
• Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response — RECRUITING · PHASE3
• Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC. — RECRUITING · PHASE2
• Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial — RECRUITING · PHASE2
• Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial — RECRUITING · PHASE3
• 40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy — RECRUITING · PHASE3
• Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC — RECRUITING · PHASE3
• Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II) — RECRUITING · PHASE2
• Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer — RECRUITING · PHASE3
• A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy — RECRUITING · PHASE2
• SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC — RECRUITING · PHASE1
• A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors — RECRUITING · PHASE2
• Individualized Elective Neck Irradiation in NPC Patients — RECRUITING · PHASE3
• Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma — RECRUITING
• Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC — RECRUITING · PHASE3
• Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• An International Study on Pediatric Patients With Rare Tumors. — RECRUITING
• Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• Screening for Early Diagnosis of Nose Cancer — RECRUITING · NA
• Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC — RECRUITING · PHASE3
• Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma — RECRUITING · PHASE2
• Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas — RECRUITING · NA
• GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. — RECRUITING · PHASE2
• Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients — RECRUITING · NA
• A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma — RECRUITING · PHASE3
• Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC — RECRUITING
• Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma — RECRUITING · NA

Refine this search